peter
morri
mbb
phd
fracp
b
c
upper
respiratori
tract
infect
includ
otiti
media
common
ill
affect
children
averag
children
experi
around
six
eight
upper
respiratori
tract
infect
urti
year
although
infect
usual
mild
self
limit
occasion
lead
complic
life
threaten
urti
place
within
three
main
categori
infect
rhinosinus
pharyng
otiti
media
within
categori
ill
rang
relat
condit
may
similar
overlap
clinic
present
judgment
requir
determin
part
respiratori
mucosa
affect
articl
term
rhinosinus
use
describ
ill
predominantli
nasal
symptom
includ
common
cold
nasopharyng
sinus
term
pharyng
use
describ
ill
sore
throat
promin
includ
tonsil
term
otiti
media
use
describ
ill
predominantli
middl
ear
symptom
includ
acut
otiti
media
aom
otiti
media
effus
ome
chronic
suppur
otiti
media
csom
children
cough
predomin
symptom
consid
bronchiti
lower
respiratori
tract
infect
make
matter
complic
area
respiratori
mucosa
may
affect
simultan
differ
time
one
ill
caus
respiratori
mucos
infect
commonli
viral
bacteri
tabl
mani
infect
involv
virus
bacteria
develop
countri
viral
bacteri
infect
like
self
limit
persist
diseas
like
indic
bacteri
infect
frequenc
infect
associ
fever
constitut
symptom
creat
signific
distress
child
famili
understand
evid
avail
highqual
studi
clinician
advis
famili
appropri
action
goal
articl
support
clinician
answer
follow
question
happen
children
condit
addit
treatment
provid
intervent
assess
welldesign
studi
intervent
shown
improv
outcom
larg
overal
benefit
urti
extrem
common
children
long
list
potenti
intervent
urti
common
ill
reason
highqual
random
control
trial
rtc
conduct
addit
famili
experi
condit
may
strong
person
prefer
treatment
challeng
clinician
make
accur
diagnosi
match
effect
treatment
option
prefer
famili
articl
initi
consid
effect
intervent
compar
intervent
condit
cover
spectrum
diseas
acut
present
initi
urti
discuss
first
appropri
intervent
persist
diseas
complic
initi
complaint
address
focu
trial
evid
inform
relev
individu
decis
may
discuss
furthermor
clinic
cours
particip
enrol
rct
may
differ
clinic
cours
observ
one
practic
overal
effect
intervent
may
need
adjust
despit
limit
clinician
use
articl
confid
understand
intervent
rigor
assess
overal
find
assess
grade
work
group
describ
step
requir
review
evid
ideal
explicit
criteria
use
although
process
mani
advantag
term
transpar
guarante
recommend
consist
across
differ
set
evidencebas
guidelin
although
consist
longterm
aim
grade
work
group
propos
recommend
indic
decis
major
wellinform
individu
would
make
difficult
dogmat
intervent
selflimit
condit
low
risk
complic
therefor
author
tri
provid
summari
evid
assist
discuss
famili
tabl
author
approach
inform
best
avail
evid
describ
box
selflimit
natur
condit
utmost
import
determin
treatment
indic
outcom
author
consid
import
persist
diseas
short
term
day
medium
term
week
month
long
term
month
time
cure
complic
aris
progress
diseas
author
consid
intervent
larg
effect
associ
reduct
outcom
interest
larg
effect
associ
reduct
outcom
interest
least
reduct
outcom
interest
consid
modest
reduct
less
consid
slight
small
proport
children
urti
experi
bad
outcom
even
larg
rel
effect
may
translat
clinic
signific
absolut
benefit
author
search
target
evidencebas
guidelin
evidencebas
summari
systemat
review
rct
intervent
rhinosinus
pharyng
otiti
media
box
even
simpl
strategi
identifi
sourc
use
pubm
alon
inclus
evidencebas
guidelin
summari
systemat
review
requir
explicit
search
strategi
criteria
studi
inclus
inclus
clinic
trial
requir
random
author
use
three
primari
sourc
identifi
relev
inform
clinic
evid
cochran
librari
medlin
last
access
via
pubm
june
evidencebas
summari
clinic
evid
link
major
guidelin
use
grade
work
group
approach
assess
qualiti
evid
strength
recommend
search
identifi
evidencebas
guidelin
evid
summari
systemat
review
mani
addit
rct
publish
sinc
upper
respiratori
tract
infect
articl
includ
intervent
assess
nonrandom
studi
intervent
assess
studi
fewer
particip
spars
data
studi
intervent
avail
experiment
rhinosinus
urti
predominantli
affect
nasal
part
respiratori
mucosa
common
cold
infect
caus
mainli
virus
typic
rhinoviru
also
coronaviru
respiratori
syncyti
viru
metapneumoviru
other
mani
cold
infect
organ
identifi
common
cold
usual
short
durat
symptom
peak
within
day
gener
clear
day
although
associ
cough
bronchiti
often
persist
peopl
acut
rhinosinus
assess
treat
primarycar
set
preced
viral
urti
often
trigger
acut
sinus
common
cold
becom
complic
develop
acut
sinus
acut
sinus
defin
patholog
transient
inflamm
mucos
line
paranas
sinus
last
less
day
clinic
acut
sinus
character
nasal
congest
nasal
discharg
facial
pain
diagnosi
acut
sinus
infant
children
usual
made
children
purul
nasal
drainag
persist
beyond
day
straightforward
case
investig
requir
complic
frequent
present
possibl
underli
factor
includ
nasal
airway
obstruct
immunodefici
ciliari
dysfunct
cystic
fibrosi
allerg
rhiniti
usual
pathogen
acut
bacteri
sinus
streptococcu
pneumonia
haemophilu
influenza
occasion
infect
moraxella
catarrhali
staphylococcu
aureu
rare
bacteri
sinus
children
lead
rare
lifethreaten
complic
mening
cavern
venou
thrombosi
orbit
cellul
children
rhinosinus
improv
spontan
within
day
complic
ill
uncommon
evid
prevent
effect
vitamin
c
echinacea
onset
ill
neither
intervent
proven
effect
evid
treatment
effect
antihistamin
vitamin
c
antibiot
decongest
zinc
lozeng
echinacea
see
tabl
intervent
decongest
proven
effect
benefici
effect
small
decongest
test
young
children
antibiot
seem
effect
individu
purul
rhinosinus
benefici
effect
modest
given
avail
evid
rct
wellinform
individu
choos
cours
watch
wait
symptomat
relief
use
analges
agent
assess
rct
would
reason
children
pain
discomfort
antibiot
option
children
purul
nasal
discharg
provid
modest
benefit
decongest
option
older
children
nasal
obstruct
probabl
worth
persist
decongest
symptomat
relief
first
dose
small
proport
children
go
develop
persist
rhinosinus
classic
sinus
evid
treatment
effect
intranas
corticosteroid
adult
studi
antibiot
intervent
seem
benefici
benefici
effect
modest
antibiot
use
consist
evid
longer
cours
treatment
r
day
effect
shorter
cours
evid
support
belief
one
commonli
use
antibiot
effect
other
although
cephalosporin
class
antibiot
seem
inferior
amoxicillinclavulan
given
avail
evid
rct
wellinform
individu
choos
either
watch
wait
trial
antibiot
intranas
corticosteroid
reason
option
older
children
particularli
featur
atopi
pharyng
acut
urti
affect
respiratori
mucosa
throat
result
predomin
symptom
pain
may
associ
headach
fever
gener
malais
unit
state
acut
pharyng
account
primari
care
consult
rank
top
diagnos
infect
lead
pharyng
viral
bacteri
tabl
difficult
distinguish
bacteri
infect
viral
infect
clinic
studi
found
tonsillar
pharyng
exud
tender
cervic
lymphadenopathi
recent
exposur
streptococc
throat
infect
use
predict
bacteri
infect
use
clinic
predict
rule
found
streptococc
infect
present
children
three
follow
featur
posit
fever
higher
c
tonsillar
swell
exud
tender
cervic
lymphadenopathi
absenc
cough
even
without
treatment
sore
throat
resolv
case
day
case
week
small
proport
children
experi
progress
ill
suppur
complic
includ
peritonsillar
abscess
quinsi
aom
acut
sinus
nonsuppur
complic
includ
acut
rheumat
fever
acut
glomerulonephr
children
pharyng
improv
spontan
within
day
complic
ill
uncommon
evid
box
simpl
pubm
search
strategi
identifi
evidencebas
guidelin
evidencebas
summari
systemat
review
randmoiz
control
trial
common
upper
respiratori
tract
infect
treatment
effect
antibiot
analges
corticosteroid
onset
ill
see
tabl
benefici
effect
analges
larg
persist
sever
day
treatment
antibiot
also
proven
effect
larg
larg
benefici
effect
prevent
complic
peritonsillar
abscess
rheumat
fever
otiti
media
complic
gener
affect
less
children
howev
antibiot
modest
shortterm
benefici
effect
improv
sore
throat
oral
penicillin
use
treatment
evid
full
cours
effect
shorter
cours
evid
system
corticosteroid
reduc
pain
within
hour
given
avail
evid
rct
wellinform
individu
choos
symptomat
relief
analges
either
watch
wait
antibiot
antibiot
would
appropri
children
increas
risk
complic
featur
consist
bacteri
infect
fever
higher
c
tonsillar
exud
enlarg
tender
cervic
node
absenc
nasal
discharg
cough
sever
pain
respond
analges
corticosteroid
option
children
sever
pain
respond
analges
larg
tonsil
may
lead
obstruct
small
proport
children
go
develop
recurr
tonsil
evid
treatment
effect
tonsillectomi
tonsillectomi
larg
benefici
effect
rate
tonsil
also
reduc
spontan
without
treatment
absolut
benefit
modest
addit
oper
associ
postop
pain
risk
complic
highqual
trial
prophylact
antibiot
treatment
done
treatment
would
reason
option
famili
want
treatment
decid
surgeri
surgeri
like
benefici
children
frequent
sever
infect
surgeri
chosen
treatment
option
cold
steel
tonsillectomi
associ
less
postop
pain
bleed
oper
diathermi
otiti
media
acut
urti
affect
respiratori
mucosa
middl
ear
cleft
common
ill
young
children
occur
much
less
frequent
children
year
old
develop
countri
otiti
media
common
indic
antibiot
prescrib
surgeri
young
children
unit
state
annual
cost
associ
otiti
media
estim
billion
otiti
media
best
regard
spectrum
diseas
import
condit
ome
aom
without
perfor
aomwop
acut
otiti
media
perfor
aomwip
csom
unfortun
current
lack
consist
definit
differ
form
otiti
media
especi
aom
gener
aom
defin
presenc
middl
ear
effus
plu
presenc
symptom
especi
pain
sign
especi
bulg
tympan
membran
fresh
discharg
diagnost
criteria
use
studi
aom
vari
use
symptomat
criteria
use
otoscop
criteria
requir
symptomat
otoscop
criteria
met
ome
usual
defin
presenc
middl
ear
effus
without
symptom
sign
acut
infect
csom
usual
defin
discharg
perfor
tympan
membran
longer
week
children
immunodefici
craniofaci
abnorm
eg
cleft
palat
syndrom
increas
risk
otiti
media
risk
factor
identifi
epidemiolog
studi
includ
recent
respiratori
infect
famili
histori
sibl
child
care
attend
lack
breast
feed
passiv
smoke
exposur
use
pacifi
children
experi
least
one
episod
aom
peak
incid
infect
occur
month
although
pathogenesi
aom
multifactori
virus
bacteria
implic
bacteria
infect
common
respiratori
pathogen
pneumonia
h
influenza
catarrhali
often
preced
viral
infect
virus
especi
respiratori
syntact
viru
influenza
caus
aom
without
coinfect
bacteria
pain
associ
aom
resolv
within
hour
around
case
within
day
around
aom
less
like
resolv
spontan
children
younger
year
complic
aom
includ
csom
mastoid
labyrinth
facial
palsi
mening
intracrani
abscess
later
sinu
thrombosi
mastoid
common
lifethreaten
complic
preantibiot
era
occur
children
admit
hospit
aom
one
studi
mastoid
complic
rare
develop
countri
csom
sever
form
otiti
media
although
lack
welldesign
longitudin
studi
csom
type
otiti
media
like
persist
without
treatment
develop
countri
csom
occur
complic
aom
perfor
major
health
issu
rang
bacteri
pathogen
associ
csom
consider
broader
seen
aom
pseudomona
staphylococcu
proteu
klebsiella
speci
commonli
isol
pathogen
mix
infect
common
multidrug
antibiot
resist
seen
often
pseudomona
infect
associ
hear
loss
usual
greater
seen
ome
csom
import
caus
moder
conduct
hear
loss
db
mani
develop
countri
develop
countri
csom
uncommon
recent
risk
factor
studi
holland
found
case
csom
occur
complic
tympanostomi
tube
insert
children
immunodefici
indigen
popul
also
greatli
increas
risk
rural
remot
commun
northern
australia
young
children
affect
ome
common
form
otiti
media
point
preval
screen
studi
around
young
children
ome
occur
spontan
compon
rhinosinus
follow
episod
aom
respiratori
bacteri
pathogen
associ
aom
implic
pathogenesi
ome
children
ome
improv
spontan
within
month
complic
ill
uncommon
averag
hear
loss
associ
ome
around
db
despit
larg
number
studi
causal
relationship
ome
speech
languag
delay
proven
children
otiti
media
usual
present
featur
relat
pain
fever
aom
hear
loss
ome
ear
discharg
aomwip
csom
children
otiti
media
detect
part
routin
examin
make
accur
diagnosi
easi
gener
good
view
whole
tympan
membran
use
either
pneumat
otoscopi
tympanometri
requir
confirm
presenc
middl
ear
effus
studi
diagnost
accuraci
aom
found
ear
pain
use
symptom
reliabl
bulg
opac
immobl
tympan
membran
highli
predict
aom
normal
color
pearli
gray
tympan
membran
make
aom
unlik
children
aom
improv
spontan
within
day
complic
ill
uncommon
evid
concern
prevent
effect
conjug
pneumococc
vaccin
influenza
vaccin
onset
ill
see
tabl
vaccin
shown
effect
benefici
effect
term
overal
rate
infect
slight
benefici
effect
conjug
pneumococc
vaccin
reduc
rate
insert
tympanostomi
tube
modest
children
fall
risk
group
also
evid
treatment
effect
antihistamin
decongest
antibiot
myringotomi
analges
see
tabl
regular
analges
paracetamol
ibuprofen
provid
benefit
assess
day
benefici
effect
larg
antibiot
also
effect
children
shortterm
benefici
effect
slight
benefici
effect
modest
children
younger
year
old
bilater
aom
larg
aomwip
studi
initi
treatment
antibiot
document
longterm
effect
antibiot
use
evid
longer
cours
treatment
r
day
effect
benefici
effect
modest
persist
aom
reduc
evid
one
commonli
use
antibiot
effect
other
use
antihistamin
decongest
shown
benefici
myringotomi
seem
harm
compar
treatment
antibiot
see
tabl
given
avail
evid
rct
aom
wellinform
individu
choos
symptomat
relief
analges
either
watch
wait
antibiot
antibiot
appropri
children
younger
year
bilater
aom
children
aomwip
children
high
risk
complic
children
alreadi
hour
watch
wait
child
highrisk
group
famili
prefer
antibiot
treatment
clinician
discuss
wait
see
prescrib
provis
script
antibiot
along
advic
use
pain
persist
hour
reduc
antibiot
use
two
third
neg
effect
famili
satisfact
small
proport
children
aom
experi
recurr
aom
three
episod
within
month
four
episod
within
month
evid
treatment
effect
prophylact
antibiot
adenoidectomi
tympanostomi
tube
insert
antibiot
proven
effect
benefici
effect
modest
rate
aom
also
reduc
spontan
without
treatment
absolut
benefit
less
impress
anticip
insert
tympanostomi
tube
also
seem
reduc
rate
aom
level
effect
similar
antibiot
either
option
could
consid
children
frequent
sever
infect
especi
infect
occur
peak
respiratori
ill
winter
children
tympanostomi
tube
may
develop
discharg
ear
howev
tympanostomi
tube
good
option
children
increas
risk
suppur
infect
includ
immunodefici
persist
bacteri
rhinosinus
children
prophylact
antibiot
prompt
antibiot
treatment
infect
probabl
appropri
choic
adenoidectomi
seem
effect
treatment
small
proport
children
aomwip
go
develop
csom
develop
countri
csom
occur
commonli
complic
tympanostomi
tube
placement
evid
treatment
effect
topic
antibiot
topic
antisept
system
antibiot
ear
clean
interpret
larg
number
small
studi
challeng
topic
antibiot
proven
effect
although
benefici
effect
vari
larg
modest
studi
document
longterm
effect
topic
antibiot
also
seem
effect
antisept
system
antibiot
role
topic
antibiot
plu
systemat
antibiot
unclear
clean
middl
ear
discharg
proven
effect
rct
gener
regard
necessari
insert
topic
antibiot
least
children
profus
discharg
although
seen
rct
also
small
risk
ototox
associ
topic
antibiot
except
topic
quinolon
topic
antisept
children
respond
prolong
cours
topic
antibiot
two
small
studi
particip
document
high
cure
rate
larg
benefici
effect
associ
week
intraven
antipseudomon
antibiot
ceftazidim
given
avail
evid
rct
csom
wellinform
individu
choos
topic
antibiot
treatment
even
though
treatment
effect
prolong
repeat
cours
treatment
often
requir
prolong
repeat
cours
topic
antibiot
need
topic
quinolon
provid
slight
benefit
term
risk
ototox
ome
affect
children
usual
asymptomat
small
proport
children
persist
ome
associ
hear
loss
evid
screen
identifi
young
children
ome
hear
loss
associ
ome
effect
develop
countri
also
evid
treatment
effect
antibiot
insert
tympanostomi
tube
autoinfl
devic
antihistamin
decongest
antibiot
plu
steroid
see
tabl
earli
insert
tympanostomi
tube
compar
watch
wait
option
later
insert
improv
hear
month
benefici
effect
modest
improv
hear
associ
improv
languag
develop
cognit
assess
score
tympanostomi
tube
usual
last
month
evid
ongo
benefit
extrud
antibiot
also
shown
effect
treatment
benefici
effect
slight
seem
persist
long
term
combin
antibiot
steroid
seem
provid
shortterm
benefit
benefici
effect
modest
evid
autoinfl
devic
effect
benefit
modest
document
short
term
antihistamin
decongest
provid
benefit
see
tabl
given
avail
evid
rct
ome
wellinform
individu
initi
choos
cours
watch
wait
children
persist
ome
ear
associ
hear
loss
despit
watch
wait
month
trial
antibiot
reason
insert
tympanostomi
tube
appropri
children
primari
concern
conduct
hear
loss
commun
difficulti
children
sever
conduct
hear
loss
like
benefit
children
experi
frequent
suppur
infect
includ
immunodefici
persist
bacteri
rhinosinus
greatest
risk
develop
csom
complic
tympanostomi
tube
famili
inform
small
proport
children
suffer
recurr
persist
ome
tympanostomi
tube
extrud
may
need
second
oper
children
tympanostomi
tube
plu
adenoidectomi
reason
option
summari
urti
common
ill
affect
children
ill
mild
resolv
complet
without
specif
treatment
multipl
intervent
assess
treatment
rhinosinus
pharyng
otiti
media
none
intervent
substanti
absolut
benefit
popul
studi
therefor
children
symptomat
relief
watch
wait
includ
educ
parent
import
danger
sign
appropri
treatment
option
antibiot
role
children
persist
bacteri
infect
risk
complic
